Stay informed with the latest updates for the inheritable blood disorders community. IndustryBayer Enrolls Patients in Longer-acting rFVIII Trial, Announces…Aug 1, 2012 IndustryNovo Nordisk Announces HERO Study ResultsAug 1, 2012 IndustryBaxter Announces New ADVATE Dosage StrengthAug 1, 2012 IndustryFDA Puts Clinical Hold on Inspiration's Trials of rFIXAug 1, 2012 IndustryBayer Announces 2012 BHAP Award RecipientsAug 1, 2012 IndustryBaxter and Chatham Partner to Develop Hemophilia TreatmentsJul 1, 2012 IndustryCSL Behring Announces Orphan Drug Designation for rFIX TherapyJul 1, 2012 IndustryAchillion Begins Trial of New HCV Drug ACH-3102, Announces Fast Track…Jun 1, 2012 IndustryNasalCEASE Gives Back to NHF ResearchJun 1, 2012 IndustryCSL Doses First Inhibitor Patients in Trial of New rFVII ProductMay 1, 2012 IndustryInspiration Files for Licensing of rFIX DrugMay 1, 2012 IndustryVertex Announces Interim Results of Telaprevir Studies in Co-Infected…Apr 1, 2012 IndustryOkairos Begins Next Phase of HCV Vaccine StudyApr 1, 2012 IndustryCSL Announces First Patient Screened for New rFVIII TrialApr 1, 2012 IndustryBayer Stresses Filtration Step for Kogenate FS UsersApr 1, 2012 Pagination First page Previous page … Page 16 Page 17 Page 18 Page 19 Current page 20 Page 21 Page 22 Page 23 Page 24 Next page Last page
